Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2906

1.

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma.

J├╝hling F, Hamdane N, Crouchet E, Li S, El Saghire H, Mukherji A, Fujiwara N, Oudot MA, Thumann C, Saviano A, Roca Suarez AA, Goto K, Masia R, Sojoodi M, Arora G, Aikata H, Ono A, Tabrizian P, Schwartz M, Polyak SJ, Davidson I, Schmidl C, Bock C, Schuster C, Chayama K, Pessaux P, Tanabe KK, Hoshida Y, Zeisel MB, Duong FH, Fuchs BC, Baumert TF.

Gut. 2020 Mar 26. pii: gutjnl-2019-318918. doi: 10.1136/gutjnl-2019-318918. [Epub ahead of print]

2.

Uptake of collagen type I via macropinocytosis cause mTOR activation and anti-cancer drug resistance.

Yamazaki S, Su Y, Maruyama A, Makinoshima H, Suzuki J, Tsuboi M, Goto K, Ochiai A, Ishii G.

Biochem Biophys Res Commun. 2020 Mar 19. pii: S0006-291X(20)30552-0. doi: 10.1016/j.bbrc.2020.03.067. [Epub ahead of print]

PMID:
32201076
3.

Subacute cutaneous lupus erythematosus with melanocyte elimination induced by pembrolizumab.

Ogawa-Momohara M, Muro Y, Goto K, Obuse C, Satoh M, Kono M, Akiyama M.

J Dermatol. 2020 Mar 15. doi: 10.1111/1346-8138.15316. [Epub ahead of print] No abstract available.

PMID:
32173880
4.

Investigation of the Utility and Safety of Dynamic Computed Tomography with Vasodilators.

Watanabe J, Endo K, Tanaka Y, Goto K, Urushibara S, Osaki T, Tatebe S, Nakamura S, Hirooka Y, Ikeguchi M.

Yonago Acta Med. 2020 Jan 24;63(1):47-54. doi: 10.33160/yam.2020.02.007. eCollection 2020 Feb.

5.

Identification and functional characterisation of N-linked glycosylation of the orphan G protein-coupled receptor Gpr176.

Wang T, Nakagawa S, Miyake T, Setsu G, Kunisue S, Goto K, Hirasawa A, Okamura H, Yamaguchi Y, Doi M.

Sci Rep. 2020 Mar 10;10(1):4429. doi: 10.1038/s41598-020-61370-y.

6.

A short form of gross motor function measure for Fukuyama congenital muscular dystrophy.

Sato T, Adachi M, Matsuo A, Zushi M, Goto K, Hirose M, Ishiguro K, Shichiji M, Murakami T, Ikai T, Osawa M, Kondo I, Nagata S, Ishigaki K.

Brain Dev. 2020 Mar 4. pii: S0387-7604(20)30085-1. doi: 10.1016/j.braindev.2020.02.006. [Epub ahead of print]

PMID:
32145987
7.

Preoperative concurrent endocrine therapy with chemotherapy in luminal B-like breast cancer.

Matsunuma R, Watanabe T, Hozumi Y, Koizumi K, Ito Y, Maruyama S, Ogura H, Goto K, Mori H, Sawai N, Shiiya N.

Breast Cancer. 2020 Mar 6. doi: 10.1007/s12282-020-01077-0. [Epub ahead of print]

PMID:
32144735
8.

Impact of high-density mapping on outcome of the second ablation for atrial fibrillation.

Ikeda Y, Kato R, Mori H, Tsutsui K, Goto K, Nagase T, Tanaka S, Asano S, Tawara M, Yukino M, Hasegawa S, Nakano S, Iwanaka S, Muramatsu T, Matsumoto K.

J Interv Card Electrophysiol. 2020 Mar 6. doi: 10.1007/s10840-020-00716-y. [Epub ahead of print]

PMID:
32144678
9.

TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer.

Oxnard GR, Yang JC, Yu H, Kim SW, Saka H, Horn L, Goto K, Ohe Y, Mann H, Thress KS, Frigault MM, Vishwanathan K, Ghiorghiu D, Ramalingam SS, Ahn MJ.

Ann Oncol. 2020 Apr;31(4):507-516. doi: 10.1016/j.annonc.2020.01.013. Epub 2020 Jan 24.

PMID:
32139298
10.

Microtubule-associated protein tau (MAPT) is a promising independent prognostic marker and tumor suppressive protein in clear cell renal cell carcinoma.

Han X, Sekino Y, Babasaki T, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.

Urol Oncol. 2020 Mar 2. pii: S1078-1439(20)30051-X. doi: 10.1016/j.urolonc.2020.02.010. [Epub ahead of print]

PMID:
32139291
11.

Sacroiliac joint degeneration is common in patients with end-stage hip osteoarthritis secondary to unilateral developmental dysplasia of the hip: Factors associated with its severity and laterality.

Okuzu Y, Goto K, Shimizu Y, Kawai T, Kuroda Y, Matsuda S.

J Orthop Sci. 2020 Mar 3. pii: S0949-2658(20)30055-5. doi: 10.1016/j.jos.2020.02.005. [Epub ahead of print]

PMID:
32139269
12.

Feasibility and utility of transbronchial cryobiopsy in primary lung cancer: Prospective, single arm study.

Kirita K, Udagawa H, Matsumoto S, Yoh K, Niho S, Goto K.

Ann Oncol. 2019 Apr;30 Suppl 2:ii76. doi: 10.1093/annonc/mdz065.009. No abstract available.

13.

Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study.

Shimokawa M, Nosaki K, Seto T, Ohashi K, Morise M, Fujiwara Y, Sakakibara J, Murakami H, Yano S, Satouchi M, Matsumoto S, Goto K, Yoh K.

Ann Oncol. 2019 Apr;30 Suppl 2:ii66. doi: 10.1093/annonc/mdz063.079. No abstract available.

14.

A SNARE geranylgeranyltransferase essential for the organization of the Golgi apparatus.

Shirakawa R, Goto-Ito S, Goto K, Wakayama S, Kubo H, Sakata N, Trinh DA, Yamagata A, Sato Y, Masumoto H, Cheng J, Fujimoto T, Fukai S, Horiuchi H.

EMBO J. 2020 Mar 3:e104120. doi: 10.15252/embj.2019104120. [Epub ahead of print]

PMID:
32128853
15.

Docetaxel Upregulates HMGB1 Levels in Non-small Cell Lung Cancer.

Haruna M, Hirata M, Iwahori K, Kanazawa T, Yamamoto Y, Goto K, Kawashima A, Morimoto-Okazawa A, Funaki S, Shintani Y, Kumanogoh A, Wada H.

Biol Pharm Bull. 2020;43(3):399-403. doi: 10.1248/bpb.b19-00702.

16.

Resistance exercise causes greater serum hepcidin elevation than endurance (cycling) exercise.

Goto K, Kojima C, Kasai N, Sumi D, Hayashi N, Hwang H.

PLoS One. 2020 Feb 27;15(2):e0228766. doi: 10.1371/journal.pone.0228766. eCollection 2020.

17.

A Case of Cerebral Small Vessel Disease Related to a Heterozygous Nonsense Mutation in HTRA1.

Ohta K, Ozawa T, Fujinaka H, Goto K, Nakajima T.

Intern Med. 2020 Feb 26. doi: 10.2169/internalmedicine.4041-19. [Epub ahead of print]

18.

Impact of radiological morphology of clinical T1 renal cell carcinoma on the prediction of upstaging to pathological T3.

Teishima J, Hayashi T, Kitano H, Sadahide K, Sekino Y, Goto K, Inoue S, Honda Y, Sentani K, Awai K, Yasui W, Matsubara A.

Jpn J Clin Oncol. 2020 Feb 26. pii: hyz154. doi: 10.1093/jjco/hyz154. [Epub ahead of print]

PMID:
32100866
19.

Clinical phenotypes based on clinical prognostic factors in patients with secondary hip osteoarthritis: preliminary findings from a prospective cohort study.

Tateuchi H, Akiyama H, Goto K, So K, Kuroda Y, Ichihashi N.

Clin Rheumatol. 2020 Feb 22. doi: 10.1007/s10067-020-04988-7. [Epub ahead of print]

PMID:
32088798
20.

Targeting claudin-4 enhances chemosensitivity in breast cancer.

Luo Y, Kishi S, Sasaki T, Ohmori H, Fujiwara-Tani R, Mori S, Goto K, Nishiguchi Y, Mori T, Kawahara I, Kondoh M, Kuniyasu H.

Cancer Sci. 2020 Feb 22. doi: 10.1111/cas.14361. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center